SRPT

Sarepta Therapeutics, Inc. News Headlines

$13.8
*  
0.30
2.22%
Get SRPT Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading SRPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SRPT Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Earnings Reaction History: Sarepta Therapeutics, Inc., 50.0% Follow-Through Indicator, 8.6% Sensitive
2/27/2014 6:25:25 AM - MT Newswires


Sarepta (SRPT) Enters Overbought Territory - Tale of the Tape
2/26/2014 6:52:01 AM - Zacks.com


SRPT: Insiders vs. Shorts
2/25/2014 2:26:53 PM - BNK Invest


Chen Lin's Perfect Biotech Market Prescription: Buy Low, Sell High
2/21/2014 10:00:00 AM - Seeking Alpha


Do Away With The Pill-A-Day Biotech Model: Steve Brozak
2/7/2014 2:05:00 PM - Seeking Alpha


How Sarepta Trading Will Evolve
1/23/2014 5:56:00 AM - Seeking Alpha


Professional Investor Explains His 2 Largest Healthcare Holdings
1/22/2014 12:48:00 PM - Seeking Alpha


Professional Investor Explains His 2 Largest Healthcare Holdings
1/22/2014 9:50:00 AM - Seeking Alpha


Sarepta Therapeutics (SRPT) Soars: Stock Up 40.1% - Tale of the Tape
1/17/2014 9:39:01 AM - Zacks.com


Pre-Market Most Active for Jan 16, 2014 : BBY, BAC, C, BHP, JCP, FOX, RESI, SRPT, FB, AMRN, MU, DRYS
1/16/2014 8:39:56 AM - NASDAQ.com News


Sector Update: Healthcare Shares Flat Pre-Market; Sarepta Therapeutics Drops 6% as Citi Cuts Rating to Sell from Neutral
1/6/2014 8:32:27 AM - MT Newswires


Sector Update: Healthcare
1/6/2014 8:31:45 AM - MT Newswires


Jason Napodano Positions For 2014: Biotech M&A Growth Trend To Continue
12/31/2013 10:45:00 AM - Seeking Alpha


Eteplirsen's Competitive Advantage Is Setting Up Sarepta For 2014
12/25/2013 7:57:00 AM - Seeking Alpha


Sarepta Down on FDA's Response - Analyst Blog
11/13/2013 12:05:38 PM - Zacks.com


US Stocks Turn Lower Amid Dallas Fed Taper Talk; Earnings Disappoint
11/12/2013 9:11:00 AM - MT Newswires


US Futures Take A Breather After Rally; Dallas Fed Chief Says Tapering May have to Start Soon
11/12/2013 8:43:41 AM - MT Newswires


Pre-Market Most Active for Nov 12, 2013 : SRPT, HOLX, AA, MO, VOD, CTL, VNDA, DIS, MU, TSM, ALU, WYNN
11/12/2013 8:38:59 AM - NASDAQ.com News


Sector Update: Healthcare Shares Lower; Sarepta Drops 50% As New Drug Application Dubbed Premature
11/12/2013 8:23:54 AM - MT Newswires


Sector Update: Healthcare
11/12/2013 8:14:26 AM - MT Newswires


A Rebuttal Of The Sarepta Bull Rebuttal
11/6/2013 6:06:00 AM - Seeking Alpha


2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts
11/1/2013 11:48:00 AM - Seeking Alpha


A Look Back At Biotech Short Picks
10/31/2013 2:18:00 PM - Seeking Alpha


Sarepta Therapeutics: Underappreciated Clinical And Regulatory Risk Following Analysis Of Prosensa Failure
10/30/2013 11:12:00 AM - Seeking Alpha


Short Sarepta: DMD Drug Prognosis Is Dismal
10/30/2013 7:00:00 AM - Seeking Alpha